ArticleAnnals of translational medicine2020
Association between type 2 diabetes and cancer incidence in China: data in hospitalized patients from 2006 to 2013.
Article in Annals of translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A large-scale, observational study to investigate the current status of diabetes complication and their prevention in Japan: incidence/risk factors for malignancies during follow-up-JDCP study 11 (English version).Diabetology international · 2024Guideline
- Glucose Intolerance and Cancer Risk: A Community-Based Prospective Cohort Study in Shanghai, China.Frontiers in oncology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEvidence of a role for type 2 diabetes in overall cancer risk is limited in ethnic Chinese populations. We therefore investigated whether there is an association between diabetes and cancer incidence.
methodsAll type 2 diabetes and cancer hospitalized patients from the First Affiliated Hospital of Nanjing Medical University between 2006.01 and 2013.12 were eligible for the study. Our research used healthcare information technology and statistical methods to analyze the clinical data of hospitalized patients and explored the relationship between diabetes and cancer. Participants with fasting glucose ≥126 mg/dL, or taking hypoglycemic medications, were classed as having type 2 diabetes. Cancer incidence was established through regular follow-up interviews and medical records. Data were entered into Excel and a database was set up with ACCESS software. Clinical information such as demographics like gender, age, occupation, marriage, insurance and etc., diagnoses, and prescription record were chosen and analyzed. SPSS software was also used for statistical analysis.
resultsThe number of patients with both diabetes and cancer rose from 220 cases in 2006 to 1,623 cases in 2013. The proportion of cancer patients with diabetes has also increased every year. Younger participants (aged ≤50 years) with diabetes had a greater risk of all cancers [P<0.005, odds ratio (OR) >3.4]. And cancer patients with diabetes occurs more frequently in male patients than in female patients, especially since 2009 the proportion has increased more evidently (P<0.005, OR >1.4). Further analysis showed that the level of blood lipid in patients with diabetes mellitus and cancer was significantly different from that in patients with simple diabetes mellitus (P<0.05).
conclusionsOur results clearly demonstrate a positive association between diabetes and cancer, especially in younger individuals aged less than 50 years. This finding highlights a need for greater awareness among public health workers and physicians of the importance of effective control of diabetes in the younger population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.